Other
Exemestane
Approved medication on the FAA's breast cancer worksheet (aromatase inhibitor)
Other names: Aromasin
Taken for: Breast cancerTaking it for something else? The entries here do not cover that use. The FAA may address it in the guidance for your condition. Ask your examiner.
Examiner
CACI: the examiner can issue when the condition's worksheet criteria are met. Applicants for first- or second-class must provide the worksheet's information annually; applicants for third-class with each required exam
For breast cancer, the FAA's CACI – Breast Cancer Worksheet lists the aromatase inhibitors anastrozole (Arimidex), letrozole (Femara) and exemestane (Aromasin) among its approved medications, when the one used is being well tolerated with no side effects.
Track your medicationsMore detail: exemestaneThe rest of Crosscheck's reading, in plain wordsOpen
The worksheet applies when the pathology showed carcinoma in situ (Tis), stage 0, ductal or lobular carcinoma in situ, or Paget disease of the breast, with all its other criteria, and the examiner must note in Block 60 one of its statements, which include CACI qualified and not CACI qualified.
Show the FAA's words: exemestaneThe official FAA wording: one passage, each with its document and dateOpen
The pathology showed:
Carcinoma in Situ (Tis), Stage 0;
Ductal Carcinoma in Situ (DCIS);
Lobular Carcinoma in Situ (LCIS);
Paget disease of the breast (Tis)
Current medication(s):
Approved medications include:
tamoxifen (Nolvadex);
Aromatase inhibitors: anastrozole (Arimidex), letrozole (Femara), or exemestane (Aromasin)
An approved medication that is being well tolerated with no side effects
AME MUST NOTE in Block 60 one of the following:
CACI qualified breast cancer (Documents do not need to be submitted to the FAA.)
NOT CACI qualified breast cancer.